|
Sustained, target delivery for treatment of cervical pathologies
|
5R43CA162417-02
|
$45,061
|
$45,061
|
Spencer, WENDY
|
3P BIOTECHNOLOGIES, INC.
|
|
Expanded Phase II Trial of Carraguard for Prevention of HPV Infection
|
5R01CA148966-04
|
$735,147
|
$735,147
|
EINSTEIN, MARK
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
2P30CA013330-40
|
$3,589,611
|
$179,481
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Core Support for Cancer Center
|
3P30CA013330-40S1
|
$75,000
|
$3,750
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Nemours Community Clinical Oncology Program
|
1U10CA176879-01
|
$558,366
|
$44,669
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
Community Clinical Oncology Program
|
5U10CA037422-26
|
$2,811,894
|
$224,952
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Prevention of EtOH-induced promotion of hepatocarcinogenesis by genistein/soy
|
5R21CA169389-02
|
$151,293
|
$151,293
|
Ronis, Martin
|
ARKANSAS CHILDREN'S HOSPITAL RES INST
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-24
|
$486,165
|
$38,893
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
ESTROGEN RECEPTOR TARGETED TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER
|
1K23CA160664-01A1
|
$142,986
|
$142,986
|
Godoy, Guilherme
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-29
|
$612,504
|
$49,000
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
A metabolic role for PML in tumor suppression
|
5R01CA142780-04
|
$329,206
|
$82,302
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Controlling cancer with aspirin-triggered stimulation of resolution
|
7R01CA170549-02
|
$492,372
|
$492,372
|
Panigrahy, Dipak
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Feasibility of grape seed extract for lung cancer chemoprevention
|
1R21CA173211-01A1
|
$174,918
|
$174,918
|
MAO, JENNY
|
BIOMEDICAL RESEARCH INSTITUTE OF NEW MEX
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S3
|
$501,282
|
$40,103
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S4
|
$122,789
|
$9,823
|
Kachnic, Lisa
|
BOSTON MEDICAL CENTER
|
|
Cancer and Leukemia Group B CCOP Research Base
|
3U10CA037447-28S1
|
$362,418
|
$28,993
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-29
|
$2,684,982
|
$214,799
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-22
|
$1,669,985
|
$1,669,985
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Selenoproteins as targets for cancer prevention
|
2R01CA080946-13A1
|
$313,928
|
$313,928
|
Gladyshev, Vadim
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITamin D and omegA-3 triaL (VITAL)
|
3U01CA138962-05S1
|
$154,236
|
$154,236
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITamin D and omegA-3 triaL (VITAL)
|
5U01CA138962-05
|
$1,849,208
|
$1,849,208
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Plasma Lipid Markers and Cancer Risk
|
5R03CA159399-02
|
$82,935
|
$41,468
|
Song, Yiqing
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-14
|
$4,589,191
|
$321,243
|
Stampfer, Meir
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Carle Cancer Center Community Clinical Oncology Program
|
2U10CA035195-30
|
$828,213
|
$66,257
|
ROWLAND, KENDRITH
|
CARLE FOUNDATION
|
|
GENETIC DETERMINANTS OF BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA
|
5U54CA163060-03
|
$1,268,396
|
$76,104
|
CHAK, AMITABH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Identification of the molecular mechanism of a potent chemopreventive agent, CDDO
|
5F31CA134211-05
|
$43,601
|
$43,601
|
Gatbonton, Tonibelle
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Clinical Oncology Research Career Development Program (CORP)
|
2K12CA076917-16
|
$721,474
|
$72,147
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-23
|
$4,740,480
|
$331,834
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-23S2
|
$37,026
|
$2,592
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Molecular Mechanisms of Prostate Cancer Chemoprevention by Apigenin
|
5R01CA108512-09
|
$224,472
|
$224,472
|
GUPTA, SANJAY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Small Molecule Induction of 15-PGDH: A Target in Colon Cancer Chemoprevention
|
1R01CA168586-01A1
|
$328,110
|
$328,110
|
Letterio, John
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case GI SPORE
|
5P50CA150964-03
|
$2,150,501
|
$193,545
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Effect of Rhamnetin on Oxidative Stress and Prostate Cancer
|
5R03CA166231-02
|
$73,790
|
$73,790
|
Shukla, Sanjeev
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Triterpenoid Modulators of Inflammatory Driven Carcinogenesis
|
5R01CA157735-03
|
$297,391
|
$297,391
|
Tochtrop, Gregory
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Community Clinical Oncology Program Research Base
|
5U10CA095861-12
|
$1,884,051
|
$150,724
|
POLLOCK, BRAD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Vitamin D3 Inhibition of Hedgehog Signaling and Cancer Chemoprevention
|
5R01CA142879-04
|
$303,665
|
$303,665
|
Epstein, Ervin
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
S1P Lyase in colon cancer
|
2R01CA129438-06
|
$314,090
|
$78,523
|
SABA, JULIE
|
CHILDREN'S HOSPITAL & RES CTR AT OAKLAND
|
|
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells
|
1R01CA172896-01A1
|
$347,041
|
$347,041
|
Kim, Yong-Mi
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Delaware/Christiana Care Community Clinical Oncology Program
|
5U10CA045418-27
|
$1,543,934
|
$123,515
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Cancer Center Support Grant
|
2P30CA033572-30
|
$2,042,489
|
$61,275
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-30S1
|
$125,000
|
$3,750
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-30S2
|
$52,354
|
$1,571
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-30S3
|
$10,680
|
$320
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Low Dose Tamoxifen in Hodgkin Lymphoma Survivors for Breast Cancer Risk Reduction
|
5R01CA140245-04
|
$571,394
|
$571,394
|
PALOMARES, MELANIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CCOP: Colorado Cancer Research Program
|
5U10CA067753-18
|
$1,136,278
|
$90,902
|
Sturtz, Keren
|
COLORADO CANCER RESEARCH PROGRAM, INC.
|
|
Dietary Rice Bran Phytochemicals and Microbial Metabolites for Colon Chemoprevent
|
5R21CA161472-02
|
$148,587
|
$148,587
|
Weir, Tiffany
|
COLORADO STATE UNIVERSITY
|
|
Leadership Component in Chemoprevention: Mouse Models of Human Cancer Consortium
|
5U01CA141535-05
|
$377,353
|
$377,353
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-39S3
|
$3,546,194
|
$106,386
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-39S4
|
$75,000
|
$2,250
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-39S5
|
$125,000
|
$3,750
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
Total relevant funding to Chemoprevention for this search: $115,022,141
|